Filing Details

Accession Number:
0001140361-23-032854
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-03 18:16:28
Reporting Period:
2023-07-03
Accepted Time:
2023-07-03 18:16:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1559053 Prothena Corp Public Ltd Co PRTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582306 J. Dennis Selkoe C/O Prothena Biosciences Inc
331 Oyster Point Boulevard
South San Francisco CA 94080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share Acquisiton 2023-07-03 5,000 $11.33 7,845 No 4 M Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2023-07-03 5,000 $67.43 2,845 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2023-07-03 5,000 $0.00 5,000 $11.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2030-05-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share 1,363 Indirect By wife
Footnotes
  1. The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
  2. All shares subject to the option have fully vested.